Submit Deal

ADDIMMUNE

Summary

Addimmune is a clinical-stage gene and cell therapy company developing a functional cure for HIV

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 628 M

Avg. Deal Size£ 628 M

Market Context

Senior Management

Sort

Target: ADDIMMUNE

Bidder: 10X CAPITAL VENTURE ACQUISITION III

4 Service Providers

4 Dealmakers

£ 627 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy